Published in Chest on May 01, 1994
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res (2013) 1.86
Stable chronic obstructive pulmonary disease. BMJ (1999) 1.50
The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res (2013) 1.37
Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis (2006) 1.11
Chronic obstructive pulmonary disease. Indian J Med Res (2013) 1.02
Tackling COPD: a multicomponent disease driven by inflammation. MedGenMed (2006) 0.95
The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med (2014) 0.92
Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study. Int J Chron Obstruct Pulmon Dis (2014) 0.91
Safety, tolerability and risk benefit analysis of tiotropium in COPD. Int J Chron Obstruct Pulmon Dis (2008) 0.89
Indacaterol: a comprehensive review. Int J Chron Obstruct Pulmon Dis (2013) 0.86
Chronic obstructive pulmonary diseases related health resources allocation in hunan province of china. Iran J Public Health (2013) 0.84
Review of ventilatory techniques to optimize mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 0.83
Pharmacological treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2006) 0.82
Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis (2014) 0.81
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study. BMC Pulm Med (2011) 0.80
Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway. Curr Opin Pharmacol (2014) 0.79
Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Integrated management strategies for chronic obstructive pulmonary disease. J Multidiscip Healthc (2010) 0.78
Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life. Int J Chron Obstruct Pulmon Dis (2015) 0.77
Tiotropium bromide. Int J Chron Obstruct Pulmon Dis (2006) 0.76
Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Update in internal medicine. Arch Med Res (2000) 0.75
Optimizing bronchodilator therapy in emphysema. Proc Am Thorac Soc (2008) 0.75
Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease. Pulm Med (2011) 0.75
Recent advances in the management of chronic obstructive pulmonary disease. F1000Res (2017) 0.75